BIOMAT Database Logo BIOMAT Database Logo

[Effect of saralasin on the activity of the renin-angiotensin-aldosterone system, sympathetic-adrenal system and the level of the 6-keto-PGF1 alpha metabolite of prostacyclin in patients with primary arterial hypertension]. 1985

E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate

Related Publications

E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[Effect of psychological stress on the activity of the sympathetic-adrenal system and blood levels of PGE2, PGF2 alpha and 6-keto-PGF1 alpha in patients with primary arterial hypertension].
October 1984, Polskie Archiwum Medycyny Wewnetrznej,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[Activity of the sympathetic-adrenal system and blood renin level in adolescents with primary arterial hypertension].
August 1974, Vrachebnoe delo,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol.
February 1983, The American journal of cardiology,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
January 1998, Terapevticheskii arkhiv,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat.
May 1979, Prostaglandins,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[The renin-angiotensin-aldosterone system in acromegaly patients with arterial hypertension].
January 1985, Minerva endocrinologica,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
Renin-angiotensin-aldosterone system in arterial hypertension.
January 1980, Cor et vasa,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[Renin-angiotensin-aldosterone system in arterial hypertension].
August 1990, Arquivos brasileiros de cardiologia,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[The renin-angiotensin-aldosterone system in arterial hypertension].
January 1971, Kardiologia polska,
E Bar-Andziak, and H Ignatowska-Switalska, and B Wocial, and M Kabat, and M Makowiecka-Cieśla, and I Cybulska, and M Sznajderman
[The renin-angiotensin-aldosterone system in arterial hypertension].
January 1971, Kardiologia polska,
Copied contents to your clipboard!